PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8463255-0	1993	A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene.	Tetradecanoylphorbol Acetate	92-128	ETS proto-oncogene 2, transcription factor	Homo sapiens	53-58	
12646185-6	2003	Furthermore, this activity was enhanced by protein kinase C activator, phorbol 12-myristate 13-acetate (PMA), in an ETS consensus-dependent manner, while PMA could also enhance the expression level of ETS2.	Tetradecanoylphorbol Acetate	71-102	ETS proto-oncogene 2, transcription factor	Homo sapiens	201-205	
12646185-6	2003	Furthermore, this activity was enhanced by protein kinase C activator, phorbol 12-myristate 13-acetate (PMA), in an ETS consensus-dependent manner, while PMA could also enhance the expression level of ETS2.	Tetradecanoylphorbol Acetate	104-107	ETS proto-oncogene 2, transcription factor	Homo sapiens	201-205	
10454570-0	1999	Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate.	Tetradecanoylphorbol Acetate	202-231	ETS proto-oncogene 2, transcription factor	Homo sapiens	83-88	
8463255-9	1993	These data suggest that the PEA-3 site, but not the activator protein-1 site, and Ets-2 protein have a major role in the TPA induction of the human stromelysin gene transcription.	Tetradecanoylphorbol Acetate	121-124	ETS proto-oncogene 2, transcription factor	Homo sapiens	82-87	
2149958-9	1990	After activation with the tumor promoter, TPA, the level of ETS2 elevates 5- to 20-fold.	Tetradecanoylphorbol Acetate	42-45	ETS proto-oncogene 2, transcription factor	Homo sapiens	60-64	
3062367-2	1988	When human lymphocytic CEM cells were treated with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA), the level of the ets-2 protein was quickly elevated 5- to 20-fold.	Tetradecanoylphorbol Acetate	70-106	ETS proto-oncogene 2, transcription factor	Homo sapiens	131-136	
3062367-2	1988	When human lymphocytic CEM cells were treated with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA), the level of the ets-2 protein was quickly elevated 5- to 20-fold.	Tetradecanoylphorbol Acetate	108-111	ETS proto-oncogene 2, transcription factor	Homo sapiens	131-136	
3062367-4	1988	The increase in the ets-2 protein was due to stabilization of the protein, because the protein had a half-life of more than 2 h in the presence of TPA and the ets-2 mRNA level did not increase significantly upon TPA treatment.	Tetradecanoylphorbol Acetate	147-150	ETS proto-oncogene 2, transcription factor	Homo sapiens	20-25	
3062367-4	1988	The increase in the ets-2 protein was due to stabilization of the protein, because the protein had a half-life of more than 2 h in the presence of TPA and the ets-2 mRNA level did not increase significantly upon TPA treatment.	Tetradecanoylphorbol Acetate	212-215	ETS proto-oncogene 2, transcription factor	Homo sapiens	20-25	
3062367-5	1988	The protein synthesis inhibitor cycloheximide enhanced the effect of TPA on the ets-2 protein and could itself slow turnover of the protein.	Tetradecanoylphorbol Acetate	69-72	ETS proto-oncogene 2, transcription factor	Homo sapiens	80-85